Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 25617

1.

Cellular therapy in Tuberculosis.

Parida SK, Madansein R, Singh N, Padayatchi N, Master I, Naidu K, Zumla A, Maeurer M.

Int J Infect Dis. 2015 Mar;32:32-8. doi: 10.1016/j.ijid.2015.01.016.

PMID:
25809753
2.

Cellular innate immunity and restriction of viral infection - implications for lentiviral gene therapy in human hematopoietic cells.

Kajaste-Rudnitski A, Naldini L.

Hum Gene Ther. 2015 Mar 26. [Epub ahead of print]

PMID:
25808164
3.

Anti-CMV-IgG Positivity of Donors Is Beneficial for alloHSCT Recipients with Respect to the Better Short-Term Immunological Recovery and High Level of CD4+CD25high Lymphocytes.

Jaskula E, Dlubek D, Tarnowska A, Lange J, Mordak-Domagala M, Suchnicki K, Sedzimirska M, Borowik A, Mizia S, Lange A.

Viruses. 2015 Mar 23;7(3):1391-408. doi: 10.3390/v7031391.

4.

Screening of Drugs to Treat 8p11 Myeloproliferative Syndrome Using Patient-Derived Induced Pluripotent Stem Cells with Fusion Gene CEP110-FGFR1.

Yamamoto S, Otsu M, Matsuzaka E, Konishi C, Takagi H, Hanada S, Mochizuki S, Nakauchi H, Imai K, Tsuji K, Ebihara Y.

PLoS One. 2015 Mar 24;10(3):e0120841. doi: 10.1371/journal.pone.0120841. eCollection 2015.

5.

O8.2Putting adoptive T cell therapy on the path to regulatory approval.

Ribas A.

Ann Oncol. 2015 Mar;26 Suppl 2:ii12. doi: 10.1093/annonc/mdv086.2.

PMID:
25795804
6.

IDH2 and NPM1 mutations cooperate to activate Hoxa9/Meis1 and hypoxia pathways in acute myeloid leukemia.

Ogawara Y, Takuo Katsumoto T, Aikawa Y, Shima Y, Kagiyama Y, Soga T, Matsunaga H, Seki T, Araki K, Kitabayashi I.

Cancer Res. 2015 Mar 20. pii: canres.2200.2014. [Epub ahead of print]

PMID:
25795706
7.
8.

Umbilical cord blood-derived cellular products for cancer immunotherapy.

Cany J, Dolstra H, Shah N.

Cytotherapy. 2015 Mar 17. pii: S1465-3249(15)00089-4. doi: 10.1016/j.jcyt.2015.03.005. [Epub ahead of print] Review.

PMID:
25795272
9.

B-cell reconstitution after lentiviral vector-mediated gene therapy in patients with Wiskott-Aldrich syndrome.

Castiello MC, Scaramuzza S, Pala F, Ferrua F, Uva P, Brigida I, Sereni L, van der Burg M, Ottaviano G, Albert MH, Roncarolo MG, Naldini L, Aiuti A, Villa A, Bosticardo M.

J Allergy Clin Immunol. 2015 Mar 16. pii: S0091-6749(15)00179-7. doi: 10.1016/j.jaci.2015.01.035. [Epub ahead of print]

10.

Microenvironmental remodeling as a parameter and prognostic factor of heterogeneous leukemogenesis in acute myeloid leukemia.

Kim JA, Shim JS, Lee GY, Yim HW, Kim TM, Kim M, Leem SH, Lee JW, Min CK, Oh IH.

Cancer Res. 2015 Mar 19. pii: canres.3379.2014. [Epub ahead of print]

PMID:
25791383
11.

Directional migration of adult hematopoeitic progenitors to C6 glioma in vitro.

Bryukhovetskiy IS, Mischenko PV, Tolok EV, Zaitcev SV, Khotimchenko YS, Bryukhovetskiy AS.

Oncol Lett. 2015 Apr;9(4):1839-1844. Epub 2015 Feb 10.

12.

Foamy viral vector integration sites in SCID-repopulating cells after MGMTP140K-mediated in vivo selection.

Olszko ME, Adair JE, Linde I, Rae DT, Trobridge P, Hocum JD, Rawlings DJ, Kiem HP, Trobridge GD.

Gene Ther. 2015 Mar 19. doi: 10.1038/gt.2015.20. [Epub ahead of print]

PMID:
25786870
13.

Regulation of Pulmonary Graft-versus-Host Disease by IL-26+CD26+CD4 T Lymphocytes.

Ohnuma K, Hatano R, Aune TM, Otsuka H, Iwata S, Dang NH, Yamada T, Morimoto C.

J Immunol. 2015 Mar 18. pii: 1402785. [Epub ahead of print]

PMID:
25786689
14.

Allogeneic stem cell transplantation using lymphoablative rather than myeloablative conditioning regimen for relapsed or refractory lymphomas.

Yoon JH, Jeon YW, Lee SE, Cho BS, Eom KS, Kim YJ, Lee S, Kim HJ, Min CK, Lee JW, Min WS, Cho SG.

Hematol Oncol. 2015 Mar 18. doi: 10.1002/hon.2201. [Epub ahead of print]

PMID:
25782369
15.

Improving the outcome of umbilical cord blood transplantation through ex vivo expansion or graft manipulation.

Horwitz ME, Frassoni F.

Cytotherapy. 2015 Mar 13. pii: S1465-3249(15)00068-7. doi: 10.1016/j.jcyt.2015.02.004. [Epub ahead of print] Review.

PMID:
25778757
16.

Enforced fucosylation of cord blood hematopoietic cells accelerates neutrophil and platelet engraftment after transplantation.

Popat U, Mehta RS, Rezvani K, Fox P, Kondo K, Marin D, McNiece I, Oran B, Hosing C, Olson A, Parmar S, Shah N, Andreeff M, Kebriaei P, Kaur I, Yvon E, de Lima M, Cooper LJ, Tewari P, Champlin RE, Nieto Y, Andersson BS, Alousi A, Jones RB, Qazilbash MH, Bashir Q, Ciurea S, Ahmed S, Anderlini P, Bosque D, Bollard C, Molldrem JJ, Chen J, Rondon G, Thomas M, Miller L, Wolpe S, Simmons P, Robinson S, Zweidler-McKay PA, Shpall EJ.

Blood. 2015 Mar 16. pii: blood-2015-01-607366. [Epub ahead of print]

PMID:
25778529
17.

[Chronic lymphocytic leukemia : Treatment concepts in transition].

Eichhorst B, Hallek M.

Internist (Berl). 2015 Mar 18. [Epub ahead of print] German.

PMID:
25776793
18.

Lymphoid Regeneration from Gene-Corrected SCID-X1 Subject-Derived iPSCs.

Menon T, Firth AL, Scripture-Adams DD, Galic Z, Qualls SJ, Gilmore WB, Ke E, Singer O, Anderson LS, Bornzin AR, Alexander IE, Zack JA, Verma IM.

Cell Stem Cell. 2015 Mar 11. pii: S1934-5909(15)00061-2. doi: 10.1016/j.stem.2015.02.005. [Epub ahead of print]

PMID:
25772073
19.

Cellular reprogramming allows generation of autologous hematopoietic progenitors from AML patients that are devoid of patient-specific genomic aberrations.

Salci KR, Lee JH, Laronde S, Dingwall S, Kushwah R, Fiebig-Comyn A, Leber B, Foley R, Dal Cin A, Bhatia M.

Stem Cells. 2015 Mar 12. doi: 10.1002/stem.1994. [Epub ahead of print]

PMID:
25764124
20.

Administration of hydrogen-rich saline in mice with allogeneic hematopoietic stem-cell transplantation.

Yuan L, Chen X, Qian L, Shen J, Cai J.

Med Sci Monit. 2015 Mar 12;21:749-54. doi: 10.12659/MSM.891338.

PMID:
25763677
Free PMC Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk